カテゴリ： Infiniti Research TechNavio, 世界, 医療/バイオ

世界のB型＆C型肝炎診断市場2023-2027：免疫診断薬、NAT

■ 英語タイトル：Global Hepatitis B and C Diagnostics Market 2023-2027

調査会社Technavio社が発行したリサーチレポート（データ管理コード：IRTNTR70927-23）■ 発行会社/調査会社：Technavio
■ 商品コード：IRTNTR70927-23
■ 発行日：2022年12月28日
■ 調査対象地域：北米、ヨーロッパ、アジア、その他地域
■ 産業分野：医療
■ ページ数：161
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後24時間以内）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,500 ⇒換算￥380,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD4,000 ⇒換算￥608,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Technavio社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のB型＆C型肝炎診断市場2023-2027：免疫診断薬、NAT]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Technavio社の本報告書によると、世界のB型＆C型肝炎診断市場規模が2022年から2027年まで年平均6.12%減少し、2,055.79百万ドルに達すると予想されます。本書では、B型＆C型肝炎診断の世界市場を調査・分析し、エグゼクティブサマリー、市場状況、市場規模予測、過去の市場規模、ファイブフォース分析、種類別（免疫診断薬、NAT）分析、顧客状況、地域別状況（北米、ヨーロッパ、アジア太平洋、その他地域、アメリカ、ドイツ、イギリス、日本、中国）分析、推進要因・課題・動向、企業状況、企業分析などの構成でまとめています。なお、本資料には、主要企業としてAbbott Laboratories、Bio Rad Laboratories Inc.、bioMerieux SA、DAAN Gene Co. Ltd.、DiaSorin SpA、Enzo Biochem Inc.、F. Hoffmann La Roche Ltd.、Grifols SA、Hologic Inc.、MedMira Inc.、OraSure Technologies Inc.、PerkinElmer Inc.、QIAGEN NV、Quidel Corp.、Randox Laboratories Ltd.、Siemens AG、Sysmex Corp.、Xiamen Innovax Biotech Co. Ltd.などの企業情報が含まれています。
・エグゼクティブサマリー
・市場状況
・市場規模予測
・過去の市場規模
・ファイブフォース分析
・世界のB型＆C型肝炎診断市場規模：種類別
- 免疫診断薬の市場規模
- NATの市場規模
・顧客状況
・世界のB型＆C型肝炎診断市場規模：地域別
- 北米のB型＆C型肝炎診断市場規模
- ヨーロッパのB型＆C型肝炎診断市場規模
- アジア太平洋のB型＆C型肝炎診断市場規模
- その他地域のB型＆C型肝炎診断市場規模
- アメリカのB型＆C型肝炎診断市場規模
- ドイツのB型＆C型肝炎診断市場規模
- イギリスのB型＆C型肝炎診断市場規模
- 日本のB型＆C型肝炎診断市場規模
- 中国のB型＆C型肝炎診断市場規模
・推進要因・課題・動向
・企業状況
・企業分析

Technavio社は、利益、価格、競争、プロモーションなどの主要なパラメーターを分析することにより、また複数のソースからのデータを調査、統合、および合計することにより、市場の詳細な全体像をまとめています。主要産業のインフルエンサーを特定することにより、さまざまな市場の側面を提示します。提示されたデータは包括的​​で信頼性が高く、一次および二次の広範な調査の結果です。Technavio社の市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用し、完全な競争状況と詳細なベンダー選択方法と分析を提供します。

B型＆C型肝炎診断の世界市場 2023-2027

Technavio社は、B型＆C型肝炎診断市場をモニターしており、2022年から2027年の間に2,055.79百万ドルの成長が予測され、予測期間中のCAGRは6.12%で減速すると予測しています。当レポートでは、B型＆C型肝炎診断市場について、市場規模や予測、動向、成長促進要因、課題などの全体的な分析に加え、約25のベンダーを網羅したベンダー分析も掲載しています。

当レポートでは、現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。HBVおよびHCVの診断における分子診断薬への需要の高まり、診断プロセスの簡素化に向けた医療機関の戦略、POC診断薬への需要の高まりが市場を牽引しています。

TechnavioのB型＆C型肝炎診断市場は以下のようにセグメント化されています：

・タイプ別：
– 免疫診断薬
– NAT

・地域別：
– 北米
– ヨーロッパ
– アジア
– その他の地域（ROW）

本調査では、HBVおよびHCV診断検査における免疫センサーの登場が、今後数年間のB型＆C型肝炎診断市場の成長を牽引する主要な要因の1つであると指摘しています。また、バイオマーカーに基づく検査に対する高い需要と、HBVおよびHCV診断検査に対する認識およびスクリーニングプログラムの増加は、市場の大きな需要につながるでしょう。

Technavio社は、複数の情報源からのデータを調査、統合、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。

当レポートでは、B型＆C型肝炎診断市場について以下の分野をカバーしています：
– B型＆C型肝炎診断市場のサイジング
– B型＆C型肝炎診断市場予測
– B型＆C型肝炎診断市場の産業分析

Technavio社の確実なベンダー分析は、クライアントが市場でのポジションを向上できるように設計されており、これに沿って本レポートには、Abbott Laboratories, Bio Rad Laboratories Inc., bioMerieux SA, DAAN Gene Co. Ltd., DiaSorin SpA, Enzo Biochem Inc., F. Hoffmann La Roche Ltd., Grifols SA, Hologic Inc., MedMira Inc., OraSure Technologies Inc., PerkinElmer Inc., QIAGEN NV, Quidel Corp., Randox Laboratories Ltd., Siemens AG, Sysmex Corp., and Xiamen Innovax Biotech Co. Ltdなどの企業情報が含まれています。また、B型＆C型肝炎診断市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートでは、主要ベンダーの分析に加え、包括的な市場およびベンダーの状況を掲載しています。

Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で市場の詳細な姿を提示します。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Disease Type
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global hepatitis B and C diagnostics market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on Global hepatitis B and C diagnostics market 2017 – 2021 ($ million)
o 4.2 Procedure Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Procedure Segment 2017 – 2021 ($ million)
o 4.3 Diseases Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Diseases Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Type
o 6.1 Market segments
o Exhibit 30: Chart on Type – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Type – Market share 2022-2027 (%)
o 6.2 Comparison by Type
o Exhibit 32: Chart on Comparison by Type
o Exhibit 33: Data Table on Comparison by Type
o 6.3 Immunodiagnostics – Market size and forecast 2022-2027
o Exhibit 34: Chart on Immunodiagnostics – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Immunodiagnostics – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Immunodiagnostics – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Immunodiagnostics – Year-over-year growth 2022-2027 (%)
o 6.4 NAT – Market size and forecast 2022-2027
o Exhibit 38: Chart on NAT – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on NAT – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on NAT – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on NAT – Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Type
o Exhibit 42: Market opportunity by Type ($ million)
• 7 Market Segmentation by Disease Type
o 7.1 Market segments
o Exhibit 43: Chart on Disease Type – Market share 2022-2027 (%)
o Exhibit 44: Data Table on Disease Type – Market share 2022-2027 (%)
o 7.2 Comparison by Disease Type
o Exhibit 45: Chart on Comparison by Disease Type
o Exhibit 46: Data Table on Comparison by Disease Type
o 7.3 Hepatitis B – Market size and forecast 2022-2027
o Exhibit 47: Chart on Hepatitis B – Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Data Table on Hepatitis B – Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Chart on Hepatitis B – Year-over-year growth 2022-2027 (%)
o Exhibit 50: Data Table on Hepatitis B – Year-over-year growth 2022-2027 (%)
o 7.4 Hepatitis C – Market size and forecast 2022-2027
o Exhibit 51: Chart on Hepatitis C – Market size and forecast 2022-2027 ($ million)
o Exhibit 52: Data Table on Hepatitis C – Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Chart on Hepatitis C – Year-over-year growth 2022-2027 (%)
o Exhibit 54: Data Table on Hepatitis C – Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Disease Type
o Exhibit 55: Market opportunity by Disease Type ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 57: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 58: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 59: Chart on Geographic comparison
o Exhibit 60: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 61: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 62: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 63: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 64: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 65: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 66: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 67: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 68: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 69: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 70: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 71: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 72: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 73: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 74: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 75: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 76: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 77: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 78: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 79: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 Germany – Market size and forecast 2022-2027
o Exhibit 81: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 82: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 83: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.9 UK – Market size and forecast 2022-2027
o Exhibit 85: Chart on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 86: Data Table on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 87: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.10 Japan – Market size and forecast 2022-2027
o Exhibit 89: Chart on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 90: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 91: Chart on Japan – Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on Japan – Year-over-year growth 2022-2027 (%)
o 9.11 China – Market size and forecast 2022-2027
o Exhibit 93: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 94: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 95: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 97: Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 98: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 99: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 100: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 101: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 102: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 103: Matrix on vendor position and classification
o 12.3 Abbott Laboratories
o Exhibit 104: Abbott Laboratories – Overview
o Exhibit 105: Abbott Laboratories – Business segments
o Exhibit 106: Abbott Laboratories – Key news
o Exhibit 107: Abbott Laboratories – Key offerings
o Exhibit 108: Abbott Laboratories – Segment focus
o 12.4 Bio Rad Laboratories Inc.
o Exhibit 109: Bio Rad Laboratories Inc. – Overview
o Exhibit 110: Bio Rad Laboratories Inc. – Business segments
o Exhibit 111: Bio Rad Laboratories Inc. – Key news
o Exhibit 112: Bio Rad Laboratories Inc. – Key offerings
o Exhibit 113: Bio Rad Laboratories Inc. – Segment focus
o 12.5 bioMerieux SA
o Exhibit 114: bioMerieux SA – Overview
o Exhibit 115: bioMerieux SA – Product / Service
o Exhibit 116: bioMerieux SA – Key offerings
o 12.6 DAAN Gene Co. Ltd.
o Exhibit 117: DAAN Gene Co. Ltd. – Overview
o Exhibit 118: DAAN Gene Co. Ltd. – Product / Service
o Exhibit 119: DAAN Gene Co. Ltd. – Key offerings
o 12.7 DiaSorin SpA
o Exhibit 120: DiaSorin SpA – Overview
o Exhibit 121: DiaSorin SpA – Business segments
o Exhibit 122: DiaSorin SpA – Key news
o Exhibit 123: DiaSorin SpA – Key offerings
o Exhibit 124: DiaSorin SpA – Segment focus
o 12.8 Enzo Biochem Inc.
o Exhibit 125: Enzo Biochem Inc. – Overview
o Exhibit 126: Enzo Biochem Inc. – Product / Service
o Exhibit 127: Enzo Biochem Inc. – Key offerings
o 12.9 F. Hoffmann La Roche Ltd.
o Exhibit 128: F. Hoffmann La Roche Ltd. – Overview
o Exhibit 129: F. Hoffmann La Roche Ltd. – Business segments
o Exhibit 130: F. Hoffmann La Roche Ltd. – Key news
o Exhibit 131: F. Hoffmann La Roche Ltd. – Key offerings
o Exhibit 132: F. Hoffmann La Roche Ltd. – Segment focus
o 12.10 Grifols SA
o Exhibit 133: Grifols SA – Overview
o Exhibit 134: Grifols SA – Business segments
o Exhibit 135: Grifols SA – Key offerings
o Exhibit 136: Grifols SA – Segment focus
o 12.11 Hologic Inc.
o Exhibit 137: Hologic Inc. – Overview
o Exhibit 138: Hologic Inc. – Business segments
o Exhibit 139: Hologic Inc. – Key news
o Exhibit 140: Hologic Inc. – Key offerings
o Exhibit 141: Hologic Inc. – Segment focus
o 12.12 MedMira Inc.
o Exhibit 142: MedMira Inc. – Overview
o Exhibit 143: MedMira Inc. – Product / Service
o Exhibit 144: MedMira Inc. – Key offerings
o 12.13 OraSure Technologies Inc.
o Exhibit 145: OraSure Technologies Inc. – Overview
o Exhibit 146: OraSure Technologies Inc. – Business segments
o Exhibit 147: OraSure Technologies Inc. – Key offerings
o Exhibit 148: OraSure Technologies Inc. – Segment focus
o 12.14 PerkinElmer Inc.
o Exhibit 149: PerkinElmer Inc. – Overview
o Exhibit 150: PerkinElmer Inc. – Business segments
o Exhibit 151: PerkinElmer Inc. – Key news
o Exhibit 152: PerkinElmer Inc. – Key offerings
o Exhibit 153: PerkinElmer Inc. – Segment focus
o 12.15 QIAGEN NV
o Exhibit 154: QIAGEN NV – Overview
o Exhibit 155: QIAGEN NV – Product / Service
o Exhibit 156: QIAGEN NV – Key news
o Exhibit 157: QIAGEN NV – Key offerings
o 12.16 Randox Laboratories Ltd.
o Exhibit 158: Randox Laboratories Ltd. – Overview
o Exhibit 159: Randox Laboratories Ltd. – Product / Service
o Exhibit 160: Randox Laboratories Ltd. – Key offerings
o 12.17 Siemens AG
o Exhibit 161: Siemens AG – Overview
o Exhibit 162: Siemens AG – Business segments
o Exhibit 163: Siemens AG – Key news
o Exhibit 164: Siemens AG – Key offerings
o Exhibit 165: Siemens AG – Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 166: Inclusions checklist
o Exhibit 167: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 168: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 169: Research methodology
o Exhibit 170: Validation techniques employed for market sizing
o Exhibit 171: Information sources
o 13.5 List of abbreviations
o Exhibit 172: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Type
Exhibits6: Executive Summary – Chart on Market Segmentation by Disease Type
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on Global hepatitis B and C diagnostics market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Procedure Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – Diseases Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Type – Market share 2022-2027 (%)
Exhibits31: Data Table on Type – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Immunodiagnostics – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Immunodiagnostics – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Immunodiagnostics – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Immunodiagnostics – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on NAT – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on NAT – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on NAT – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on NAT – Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Type ($ million)
Exhibits43: Chart on Disease Type – Market share 2022-2027 (%)
Exhibits44: Data Table on Disease Type – Market share 2022-2027 (%)
Exhibits45: Chart on Comparison by Disease Type
Exhibits46: Data Table on Comparison by Disease Type
Exhibits47: Chart on Hepatitis B – Market size and forecast 2022-2027 ($ million)
Exhibits48: Data Table on Hepatitis B – Market size and forecast 2022-2027 ($ million)
Exhibits49: Chart on Hepatitis B – Year-over-year growth 2022-2027 (%)
Exhibits50: Data Table on Hepatitis B – Year-over-year growth 2022-2027 (%)
Exhibits51: Chart on Hepatitis C – Market size and forecast 2022-2027 ($ million)
Exhibits52: Data Table on Hepatitis C – Market size and forecast 2022-2027 ($ million)
Exhibits53: Chart on Hepatitis C – Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on Hepatitis C – Year-over-year growth 2022-2027 (%)
Exhibits55: Market opportunity by Disease Type ($ million)
Exhibits56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits57: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits58: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits59: Chart on Geographic comparison
Exhibits60: Data Table on Geographic comparison
Exhibits61: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits62: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits63: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits64: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits65: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits66: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits67: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits68: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits69: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits70: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits71: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits72: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits73: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits74: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits75: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on UK – Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on UK – Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on Japan – Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on Japan – Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits97: Market opportunity By Geographical Landscape ($ million)
Exhibits98: Impact of drivers and challenges in 2022 and 2027
Exhibits99: Overview on Criticality of inputs and Factors of differentiation
Exhibits100: Overview on factors of disruption
Exhibits101: Impact of key risks on business
Exhibits102: Vendors covered
Exhibits103: Matrix on vendor position and classification
Exhibits104: Abbott Laboratories – Overview
Exhibits105: Abbott Laboratories – Business segments
Exhibits106: Abbott Laboratories – Key news
Exhibits107: Abbott Laboratories – Key offerings
Exhibits108: Abbott Laboratories – Segment focus
Exhibits109: Bio Rad Laboratories Inc. – Overview
Exhibits110: Bio Rad Laboratories Inc. – Business segments
Exhibits111: Bio Rad Laboratories Inc. – Key news
Exhibits112: Bio Rad Laboratories Inc. – Key offerings
Exhibits113: Bio Rad Laboratories Inc. – Segment focus
Exhibits114: bioMerieux SA – Overview
Exhibits115: bioMerieux SA – Product / Service
Exhibits116: bioMerieux SA – Key offerings
Exhibits117: DAAN Gene Co. Ltd. – Overview
Exhibits118: DAAN Gene Co. Ltd. – Product / Service
Exhibits119: DAAN Gene Co. Ltd. – Key offerings
Exhibits120: DiaSorin SpA – Overview
Exhibits121: DiaSorin SpA – Business segments
Exhibits122: DiaSorin SpA – Key news
Exhibits123: DiaSorin SpA – Key offerings
Exhibits124: DiaSorin SpA – Segment focus
Exhibits125: Enzo Biochem Inc. – Overview
Exhibits126: Enzo Biochem Inc. – Product / Service
Exhibits127: Enzo Biochem Inc. – Key offerings
Exhibits128: F. Hoffmann La Roche Ltd. – Overview
Exhibits129: F. Hoffmann La Roche Ltd. – Business segments
Exhibits130: F. Hoffmann La Roche Ltd. – Key news
Exhibits131: F. Hoffmann La Roche Ltd. – Key offerings
Exhibits132: F. Hoffmann La Roche Ltd. – Segment focus
Exhibits133: Grifols SA – Overview
Exhibits134: Grifols SA – Business segments
Exhibits135: Grifols SA – Key offerings
Exhibits136: Grifols SA – Segment focus
Exhibits137: Hologic Inc. – Overview
Exhibits138: Hologic Inc. – Business segments
Exhibits139: Hologic Inc. – Key news
Exhibits140: Hologic Inc. – Key offerings
Exhibits141: Hologic Inc. – Segment focus
Exhibits142: MedMira Inc. – Overview
Exhibits143: MedMira Inc. – Product / Service
Exhibits144: MedMira Inc. – Key offerings
Exhibits145: OraSure Technologies Inc. – Overview
Exhibits146: OraSure Technologies Inc. – Business segments
Exhibits147: OraSure Technologies Inc. – Key offerings
Exhibits148: OraSure Technologies Inc. – Segment focus
Exhibits149: PerkinElmer Inc. – Overview
Exhibits150: PerkinElmer Inc. – Business segments
Exhibits151: PerkinElmer Inc. – Key news
Exhibits152: PerkinElmer Inc. – Key offerings
Exhibits153: PerkinElmer Inc. – Segment focus
Exhibits154: QIAGEN NV – Overview
Exhibits155: QIAGEN NV – Product / Service
Exhibits156: QIAGEN NV – Key news
Exhibits157: QIAGEN NV – Key offerings
Exhibits158: Randox Laboratories Ltd. – Overview
Exhibits159: Randox Laboratories Ltd. – Product / Service
Exhibits160: Randox Laboratories Ltd. – Key offerings
Exhibits161: Siemens AG – Overview
Exhibits162: Siemens AG – Business segments
Exhibits163: Siemens AG – Key news
Exhibits164: Siemens AG – Key offerings
Exhibits165: Siemens AG – Segment focus
Exhibits166: Inclusions checklist
Exhibits167: Exclusions checklist
Exhibits168: Currency conversion rates for US$
Exhibits169: Research methodology
Exhibits170: Validation techniques employed for market sizing
Exhibits171: Information sources
Exhibits172: List of abbreviations



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 電子顕微鏡のグローバル市場2023-2027：半導体、ライフサイエンス、材料科学、ナノテクノロジー
  • 半導体パッケージング材料のグローバル市場2023-2027：有機基板、リードフレーム、ボンディングワイヤ、セラミックパッケージ、その他
  • スタチンのグローバル市場2023-2027：病院、診療所、その他
  • 世界の歯科装置市場2023～2027：研究所、病院、診療所
  • ウェアラブルパッチのグローバル市場2023-2027： 臨床用、非臨床
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(IRTNTR70927-23 )"世界のB型＆C型肝炎診断市場2023-2027：免疫診断薬、NAT" (英文：Global Hepatitis B and C Diagnostics Market 2023-2027)はTechnavio社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。